Dr Michael A Istfan, MD | |
4610 Kanawha Ave Sw, Suite 301, South Charleston, WV 25309-1367 | |
(304) 720-8701 | |
(304) 720-8702 |
Full Name | Dr Michael A Istfan |
---|---|
Gender | Male |
Speciality | Rheumatology |
Experience | 40 Years |
Location | 4610 Kanawha Ave Sw, South Charleston, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386650760 | NPI | - | NPPES |
3910000444 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 14366 (West Virginia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Charleston Area Medical Center | Charleston, WV | Hospital |
Thomas Memorial Hospital | South charleston, WV | Hospital |
Montgomery General Hospital, Inc | Montgomery, WV | Hospital |
Camden Clark Medical Center | Parkersburg, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Charleston Area Medical Center Inc | 3375441637 | 675 |
News Archive
The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.
A new intermediate step and unexpected enzymatic activity in a metabolic pathway in the body, which could lead to new drug design for psychiatric and neurodegenerative diseases, has been discovered by researchers at Georgia State University.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
A vaccine against the mosquito-borne infection dengue, the first to reach the final stage of clinical testing, "has seen 'very promising' results in Thailand, a specialist involved in the tests said on Friday," Reuters reports.
› Verified 2 days ago
Entity Name | Charleston Area Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.
A new intermediate step and unexpected enzymatic activity in a metabolic pathway in the body, which could lead to new drug design for psychiatric and neurodegenerative diseases, has been discovered by researchers at Georgia State University.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
A vaccine against the mosquito-borne infection dengue, the first to reach the final stage of clinical testing, "has seen 'very promising' results in Thailand, a specialist involved in the tests said on Friday," Reuters reports.
› Verified 2 days ago
Entity Name | Rheumatology Group Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831536507 PECOS PAC ID: 3678716313 Enrollment ID: O20130828000967 |
News Archive
The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.
A new intermediate step and unexpected enzymatic activity in a metabolic pathway in the body, which could lead to new drug design for psychiatric and neurodegenerative diseases, has been discovered by researchers at Georgia State University.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
A vaccine against the mosquito-borne infection dengue, the first to reach the final stage of clinical testing, "has seen 'very promising' results in Thailand, a specialist involved in the tests said on Friday," Reuters reports.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Michael A Istfan, MD 4610 Kanawha Ave Sw, Suite 301, South Charleston, WV 25309-1367 Ph: (304) 720-8701 | Dr Michael A Istfan, MD 4610 Kanawha Ave Sw, Suite 301, South Charleston, WV 25309-1367 Ph: (304) 720-8701 |
News Archive
The percentage of pregnant women living with HIV in South Africa "has inched up to 30.2 percent from 29.4 percent last year," according to the annual National Antenatal Sentinel HIV and Syphilis Prevalence survey released by Health Minister Aaron Motsoaledi in Pretoria on Tuesday, Agence France-Presse reports.
A new intermediate step and unexpected enzymatic activity in a metabolic pathway in the body, which could lead to new drug design for psychiatric and neurodegenerative diseases, has been discovered by researchers at Georgia State University.
Anacor Pharmaceuticals announced today that its partner GlaxoSmithKline has voluntarily paused enrollment in its current clinical trials of GSK2251052 due to a recently identified microbiological finding in a small number of patients in the Phase 2b trial of GSK '052 for the treatment of complicated urinary tract infections (cUTI).
A vaccine against the mosquito-borne infection dengue, the first to reach the final stage of clinical testing, "has seen 'very promising' results in Thailand, a specialist involved in the tests said on Friday," Reuters reports.
› Verified 2 days ago
Dr. William Alexander Wade, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4619 Kanawha Ave., Sw, South Charleston, WV 25309 Phone: 304-400-4545 Fax: 304-400-4546 | |
Dr. Joe J White Jr., MD Rheumatology Medicare: Medicare Enrolled Practice Location: 401 Division St Ste 205, South Charleston, WV 25309 Phone: 304-342-0821 Fax: 304-345-6679 | |
Dr. Franklin Scott Moore, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4501 Maccorkle Ave Sw, Suite 301, South Charleston, WV 25309 Phone: 304-768-0700 Fax: 304-768-9790 | |
Mohamad Riad Sankari, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 401 Division St Ste 205, South Charleston, WV 25309 Phone: 304-342-0821 Fax: 304-345-6679 | |
Dr. Dina Marie Criniti, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 707 Chestnut St, South Charleston, WV 25309 Phone: 304-768-8500 Fax: 304-768-8530 | |
Emily H Battle, M. D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4607 Maccorkle Ave Sw Ste 406, South Charleston, WV 25309 Phone: 304-766-4342 Fax: 304-766-3541 | |
John Ponugupati, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 401 Division St, Suite 100, South Charleston, WV 25309 Phone: 304-766-4350 Fax: 304-766-4355 |